Showcases Stock ranks

Teva Pharmaceutical Industries Limited (TEVA)
10.2 -0.42 (-3.95%) 01-17 16:02
Open: 10.67 Pre. Close: 10.62
High: 10.68 Low: 10.15
Volume: 15,848,180 Market Cap: 11218M
Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines.
Share on Facebook   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 10.709 - 10.763 10.763 - 10.797
Low: 10.024 - 10.094 10.094 - 10.139
Close: 10.1 - 10.205 10.205 - 10.272
Stock Technical Analysis
Target: Six months: 13.00
One year: 15.18
Support: Support1: 9.67
Support2: 8.77
Resistance: Resistance1: 11.13
Resistance2: 13.00
Pivot: 9.59
Moving Averages: MA(5): 10.11
MA(20): 9.70
MA(100): 8.61
MA(250): 11.04
MACD: MACD(12,26): 0.10
Signal(12,26,9): -0.01
%K %D: %K(14,3): 74.97
%D(3): 74.28
RSI: RSI(14): 57.92
52-Week: High: 20.21
Low: 6.07
Change(%): -45.6
Average Vol(K): 3-Month: 1800369
10-Days: 1661296
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.

TEVA has closed below upper band by 22.9%. Bollinger Bands are 33.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 1090.00
Shares Float (M) 1040.00
% Held by Insiders 0.48
% Held by Institutions 54.76
Shares Short (K) 70330
Shares Short Prior Month (K)
Stock Financials
EPS -3.770
Book Value (p.s.) 12.630
PEG Ratio -0.99
Profit Margin -22.88
Operating Margin 15.30
Return on Assets (ttm) 2.7
Return on Equity (ttm) -25.4
Qtrly Rev. Growth -5.9
Gross Profit (p.s.) 7.615
Sales Per Share
EBITDA (p.s.) 4.000
Qtrly Earnings Growth
Operating Cash Flow (M) 577.00
Levered Free Cash Flow (M) 1720.00
Stock Valuation
P/E -2.71
P/E Growth Ratio -0.04
P/BV 0.81
P/S 0.62
P/CF 19.27
Dividend Yield
Dividends & Splits
Dividend Pay Date 2017-12-12
Ex-Dividend Date 2017-11-27
Forward Dividend
Last Split Date
Last Split Ratio -1e+010

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator